Regents of the University of California’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-27,645
| Closed | -$767K | – | 20 |
|
|
2024
Q1 | $767K | Hold |
27,645
| – | – | 0.22% | 19 |
|
|
2023
Q4 | $796K | Hold |
27,645
| – | – | 0.1% | 18 |
|
|
2023
Q3 | $917K | Hold |
27,645
| – | – | 0.12% | 16 |
|
|
2023
Q2 | $1.01M | Hold |
27,645
| – | – | 0.13% | 15 |
|
|
2023
Q1 | $1.13M | Hold |
27,645
| – | – | 0.21% | 13 |
|
|
2022
Q4 | $1.42M | Hold |
27,645
| – | – | 0.27% | 13 |
|
|
2022
Q3 | $1.21M | Hold |
27,645
| – | – | 0.25% | 16 |
|
|
2022
Q2 | $1.45M | Hold |
27,645
| – | – | 0.29% | 15 |
|
|
2022
Q1 | $1.43M | Hold |
27,645
| – | – | 0.22% | 21 |
|
|
2021
Q4 | $1.63M | Hold |
27,645
| – | – | 0.23% | 24 |
|
|
2021
Q3 | $1.19M | Hold |
27,645
| – | – | 0.14% | 22 |
|
|
2021
Q2 | $1.08M | Hold |
27,645
| – | – | 0.14% | 20 |
|
|
2021
Q1 | $1M | Hold |
27,645
| – | – | 0.13% | 20 |
|
|
2020
Q4 | $1.02M | Sell |
27,645
-1,493
| -5% | -$54.8K | 0.15% | 19 |
|
|
2020
Q3 | $1.01M | Hold |
29,138
| – | – | 0.14% | 16 |
|
|
2020
Q2 | $904K | Hold |
29,138
| – | – | 0.13% | 17 |
|
|
2020
Q1 | $902K | Hold |
29,138
| – | – | 0.13% | 16 |
|
|
2019
Q4 | $1.08M | Hold |
29,138
| – | – | 0.57% | 17 |
|
|
2019
Q3 | $993K | Hold |
29,138
| – | – | 1.9% | 13 |
|
|
2019
Q2 | $1.2M | Hold |
29,138
| – | – | 3.38% | 10 |
|
|
2019
Q1 | $981K | Hold |
29,138
| – | – | 2.31% | 12 |
|
|
2018
Q4 | $1.21M | Sell |
29,138
-919
| -3% | -$38.1K | 2.92% | 10 |
|
|
2018
Q3 | $1.26M | Buy |
30,057
+919
| +3% | +$35.4K | 2.45% | 10 |
|
|
2018
Q2 | $1M | Hold |
29,138
| – | – | 2.62% | 10 |
|
|
2018
Q1 | $981K | Hold |
29,138
| – | – | 1.8% | 10 |
|
|
2017
Q4 | $1M | Hold |
29,138
| – | – | 1.51% | 13 |
|
|
2017
Q3 | $987K | Hold |
29,138
| – | – | 2.05% | 9 |
|
|
2017
Q2 | $929K | Hold |
29,138
| – | – | 4.08% | 8 |
|
|
2017
Q1 | $946K | Hold |
29,138
| – | – | 4.64% | 9 |
|
|
2016
Q4 | $898K | Hold |
29,138
| – | – | 3.19% | 12 |
|
|
2016
Q3 | $936K | Buy |
29,138
+69
| +0.2% | +$2.31K | 2.67% | 13 |
|
|
2016
Q2 | $971K | Sell |
29,069
-69
| -0.2% | -$2.2K | 3.27% | 11 |
|
|
2016
Q1 | $819K | Hold |
29,138
| – | – | 2.83% | 11 |
|
|
2015
Q4 | $892K | Hold |
29,138
| – | – | 2.77% | 11 |
|
|
2015
Q3 | $868K | Hold |
29,138
| – | – | 2.72% | 11 |
|
|
2015
Q2 | $927K | Hold |
29,138
| – | – | 2.6% | 10 |
|
|
2015
Q1 | $962K | Hold |
29,138
| – | – | 0.97% | 38 |
|
|
2014
Q4 | $861K | Hold |
29,138
| – | – | 0.86% | 46 |
|
|
2014
Q3 | $817K | Hold |
29,138
| – | – | 0.46% | 66 |
|
|
2014
Q2 | $821K | Buy |
+29,138
| New | +$831K | 0.44% | 68 |
|
|
2013
Q3 | $794K | Hold |
29,138
| – | – | 0.91% | 44 |
|
|
2013
Q2 | $774K | Buy |
+29,138
| New | +$805K | 0.42% | 51 |
|
Other funds holding PFE
Regents of the University of California's PFE Position: Q2 2024 in Review
Regents of the University of California sold out of Pfizer (PFE) in Q2 2024, closing a stake of 27,645 shares — an estimated $767K sold.
Regents of the University of California first reported a position in PFE in Q2 2013 and held it in 42 quarters. The position peaked at $1.63M in Q4 2021. 2,875 funds tracked by Wall St. Rank hold PFE as of Q2 2024.
- Regents of the University of California reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
- Regents of the University of California sold 27,645 Pfizer shares in Q2 2024, an estimated $767K.
- Regents of the University of California first reported a position in Pfizer in Q2 2013 and held it in 42 quarters.
- Regents of the University of California's Pfizer position peaked at $1.63M in Q4 2021.
- 2,875 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.
Based on Regents of the University of California's 13F filing for Q2 2024, filed 13 Aug 2024.